Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Filings indexed 1,254 across all filing types
Latest filing 2018-02-16 Regulatory Filings
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 15, 2018. The content describes the termination of a material definitive agreement, specifically the termination of commitments under a credit agreement. There are no financial statements or detailed financial data presented, nor is this an announcement of earnings or an annual/interim report. The document is a regulatory filing reporting a significant corporate event related to financing agreements. Given the nature of the content and the form type (8-K), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2018-02-16 English
SC 13G/A-2017
Major Shareholding Notification
2018-02-13 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-09 English
JANUS CAPITAL MANAGEMENT 12/31/17 <5% ANNUAL CLOSEOUT
Major Shareholding Notification
2018-02-06 English
FORM 4
Director's Dealing
2018-02-03 English
FORM 4
Director's Dealing
2018-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.